Serum salusin-α levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients

Hypertension Research

Volumn 31, Issue 3, 2008, Pages 463-468

  Watanabe, Takuya ^a   Suguro, Toshiaki ^a   Sato, Kengo ^b   Koyama, Takatoshi ^b   Nagashima, Masaharu ^a   Kodate, Syuusuke ^a   Hirano, Tsutomu ^a   Adachi, Mitsuru ^a   Shichiri, Masayoshi ^b   Miyazaki, Akira ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Hypertension; Intima media thickness; Plaque score; Salusin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEPTIDE DERIVATIVE; SALUSIN ALPHA; TRIACYLGLYCEROL; UROTENSIN; UROTENSIN II;

ADULT; AGE DISTRIBUTION; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOWN REGULATION; ESSENTIAL HYPERTENSION; FEMALE; FOAM CELL; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE LINEAR REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LINEAR MODELS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA; UROTENSINS;

EID: 42649139281     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.463     Document Type: Article

References (17)

1. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y: Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 2003; 9: 1166-1172.
2. Sato K, Koyama T, Tateno T, Hirata, Y, Shichiri M: Presence of immumoreactive salusin-α in human serum and urine. Peptides 2006; 27: 2561-2566.
3. Izumiyama H, Tanaka H, Egi K, Sunamori M, Hirata Y, Shichiri M: Synthetic salusins as cardiac depressors in rat. Hypertension 2005; 45: 419-425.
4. Watanabe T, Koba S, Shichiri M, et al: Impact of salusin-α and -β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008; 117: 638-648.
5. Yu F, Zhao J, Yang J, et al: Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul Pept 2004; 122: 191-197.
6. Hong-Xiao Y, Li L, Yan-Xia P, et al: Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. J Cardiovasc Pharmacol 2006; 48: 41-46.
7. Watanabe T, Kanome T, Miyazaki A, Katagiri T: Human urotensin II linking hypertension and coronary artery disease. Hypertens Res 2006; 29: 375-387.
8. Japanese Society of Hypertension: Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res 2006; 29: S1-S105.
9. Suguro T, Watanabe T, Ban Y, et al: Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 2007; 20: 211-217.
10. Hirano T, Ito Y, Koba S, et al: Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 2004; 24: 558-563.
11. Suzuki N, Shichiri M, Akashi T, et al: Systemic distribution of salusin expression in the rat. Hypertens Res 2007; 30: 1255-1262.
12. Pennings M, Meurs I, Ye D, et al: Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett 2006; 580: 5588-5596.
13. Reid JA, Wolsley C, Lau LL, et al: The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol. Eur J Vasc Endovasc Surg 2005; 30: 464-468.
14. Kooistra T, Verschuren L, de Vries-van der Weij J, et al: Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol. Arterioscler Thromb Vasc Biol 2006; 26: 2322-2330.
15. Mortsell D, Malmqvist K, Held C, Kahan T: Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J Intern Med 2007; 261: 472-479.
16. Uchiyama-Tanaka Y, Mori Y, Kishimoto N, et al: Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension. Kidney Blood Press Res 2005; 28: 111-116.
17. Shichiri M: Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities.' Nat Med 2007; 13: 661-662.